NeoImmuneTech, Inc. (KOSDAQ:950220)

NeoImmuneTech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	35,118	38,836	34,172	68,739	115,630	154,250
Short-Term Investments	12,157	11,500	-	333.38	1,445	220.29
Trading Asset Securities	-	10,487	447.36	-	-	-
Cash & Short-Term Investments	47,275	60,822	34,619	69,072	117,075	154,471
Cash Growth	130.40%	75.69%	-49.88%	-41.00%	-24.21%	116.90%
Accounts Receivable	1,344	32.37	20.37	-	-	-
Receivables	1,344	32.37	20.37	-	-	-
Prepaid Expenses	2,178	2,291	4,446	-	895.8	-
Other Current Assets	-0	658.24	249.76	3,185	-0	12,252
Total Current Assets	51,417	63,804	39,335	72,257	117,971	166,722
Property, Plant & Equipment	3,604	4,631	6,771	7,749	9,397	9,056
Other Intangible Assets	20,202	12,820	6,461	6,168	6,554	6,591
Other Long-Term Assets	923.14	793.75	12,858	4,338	5,944	4,659
Total Assets	76,147	82,048	65,426	90,511	139,865	187,027

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	4,999	3,960	6,316	7,717	12,945	17,426
Short-Term Debt	8,761	7,630	6,935	-	-	-
Current Portion of Leases	969.69	927.41	1,150	1,353	1,279	1,284
Current Income Taxes Payable	-	-	-	-	92.49	59.33
Other Current Liabilities	3,439	8,169	6,385	3,816	2,080	1,642
Total Current Liabilities	18,169	20,686	20,785	12,886	16,397	20,411
Long-Term Leases	1,550	1,934	2,686	2,555	3,572	4,511
Pension & Post-Retirement Benefits	-	169.14	257.11	151.69	142.43	-
Other Long-Term Liabilities	47.75	46.25	36.29	62.24	64.34	63.09
Total Liabilities	19,767	22,836	23,764	15,655	20,176	24,985

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.27	4.81	2.91	2.55	2.51	2.34
Additional Paid-In Capital	409,783	380,009	337,199	295,772	290,644	271,282
Retained Earnings	-383,828	-349,508	-325,185	-246,517	-190,424	-122,781
Comprehensive Income & Other	30,436	28,706	29,645	25,599	19,466	13,539
Shareholders' Equity	56,380	59,212	41,662	74,856	119,689	162,042
Total Liabilities & Equity	76,147	82,048	65,426	90,511	139,865	187,027

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	11,281	10,492	10,771	3,908	4,851	5,795
Net Cash (Debt)	35,994	50,330	23,849	65,164	112,224	148,676
Net Cash Growth	282.81%	111.04%	-63.40%	-41.93%	-24.52%	117.64%
Net Cash Per Share	288.88	427.71	241.85	659.23	1136.26	1560.75
Filing Date Shares Outstanding	37.82	143.19	494.34	494.34	494.14	492.91
Total Common Shares Outstanding	37.82	143.19	494.34	494.34	494.14	492.91
Working Capital	33,248	43,117	18,550	59,371	101,574	146,311
Book Value Per Share	1490.80	413.52	84.28	151.43	242.22	328.75
Tangible Book Value	36,177	46,392	35,200	68,689	113,136	155,452
Tangible Book Value Per Share	956.60	323.99	71.21	138.95	228.96	315.38
Machinery	4,484	4,337	6,530	5,727	4,864	3,027
Construction In Progress	-	-	-	-	-	764.66

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error